WHIMS JAMES L 4
4 · SYNAPTICS Inc · Filed Aug 12, 2020
Insider Transaction Report
Form 4
SYNAPTICS IncSYNA
WHIMS JAMES L
Director
Transactions
- Exercise/Conversion
Common Stock
2020-08-10$46.50/sh+4,500$209,250→ 31,262 total - Sale
Common Stock
2020-08-10$85.42/sh−3,106$265,313→ 28,156 total - Sale
Common Stock
2020-08-10$86.16/sh−1,031$88,832→ 27,125 total - Sale
Common Stock
2020-08-10$87.88/sh−250$21,970→ 26,875 total - Exercise/Conversion
Director Stock Option (Right to Buy)
2020-08-10−4,500→ 0 totalExercise: $46.50Exp: 2020-10-28→ Common Stock (4,500 underlying) - Sale
Common Stock
2020-08-10$88.99/sh−113$10,056→ 26,762 total
Footnotes (5)
- [F1]The shares were sold pursuant to a 10b5-1 Trading Plan dated June 2, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.78, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.65 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014.